Your browser doesn't support javascript.
loading
Thalidomide and Lenalidomide for Refractory Systemic/Cutaneous Lupus Erythematosus Treatment: A Narrative Review of Literature for Clinical Practice.
Yuki, Emily Figueiredo Neves; Silva, Clovis A; Aikawa, Nadia E; Romiti, Ricardo; Heise, Carlos Otto; Bonfa, Eloisa; Pasoto, Sandra Gofinet.
Affiliation
  • Yuki EFN; From the Rheumatology Division.
  • Silva CA; From the Rheumatology Division.
  • Aikawa NE; From the Rheumatology Division.
  • Romiti R; Dermatology Department.
  • Heise CO; Neurology Department, Hospital das Clinicas, Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), Sao Paulo, Brazil.
  • Bonfa E; From the Rheumatology Division.
  • Pasoto SG; From the Rheumatology Division.
J Clin Rheumatol ; 27(6): 248-259, 2021 Sep 01.
Article in En | MEDLINE | ID: mdl-31693649

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lupus Erythematosus, Cutaneous / Lupus Erythematosus, Systemic Type of study: Diagnostic_studies / Observational_studies / Systematic_reviews Limits: Humans Language: En Journal: J Clin Rheumatol Journal subject: FISIOLOGIA / ORTOPEDIA / REUMATOLOGIA Year: 2021 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lupus Erythematosus, Cutaneous / Lupus Erythematosus, Systemic Type of study: Diagnostic_studies / Observational_studies / Systematic_reviews Limits: Humans Language: En Journal: J Clin Rheumatol Journal subject: FISIOLOGIA / ORTOPEDIA / REUMATOLOGIA Year: 2021 Document type: Article Country of publication: United States